Related Experiment Video

Updated: Jun 10, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
09:00

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Carvedilol can prevent cardiac events in Duchenne muscular dystrophy

Tsuyoshi Matsumura1, Takuhisa Tamura, Satoshi Kuru

  • 1Department of Neurology, National Hospital Organization Toneyama National Hospital, Toyonaka, Japan. matumura@toneyama.hosp.go.jp

Internal Medicine (Tokyo, Japan)
|July 22, 2010
PubMed

Insights

Beta-blocker medication, specifically carvedilol, shows promise in preventing cardiac events in Duchenne muscular dystrophy patients. This study suggests carvedilol is safe and effective for managing heart failure in this population.

Area of Science:

  • Cardiology
  • Neuromuscular Disorders
  • Pharmacology

Background:

  • Heart failure is a critical complication in Duchenne muscular dystrophy (DMD).
  • Beta-blockers improve outcomes in adult heart failure, but their use in DMD is not well-established.
  • Assessing carvedilol's efficacy and safety in DMD patients is crucial.

Purpose of the Study:

  • To evaluate the efficacy and safety of carvedilol in DMD patients with heart failure.
  • To compare cardiac event rates and survival in DMD patients with and without carvedilol treatment.

Main Methods:

  • A multicenter open trial involving 54 DMD patients.
  • 41 patients received carvedilol (BB group), 13 did not (non-BB group).
  • Cardiac function and clinical signs were monitored; patients with ejection fraction <50% received ACE inhibitors.

Main Results:

  • The carvedilol group had a higher survival rate free from primary endpoints (death, heart failure deterioration, severe arrhythmia).
  • Higher mean heart rates and lower carvedilol doses were observed in patients experiencing primary endpoints.
  • Carvedilol introduction was generally safe, though patients with advanced dysfunction required longer titration and experienced minor complaints.

Conclusions:

  • Carvedilol appears to be relatively safe for DMD patients.
  • Carvedilol may help prevent cardiac events in DMD patients.
  • Further research may support carvedilol as a standard treatment for DMD-associated heart failure.
Abstract

More Related Videos

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...